Pharmacokinetics and toxicity of intraarterial Adriamycin for hepatocellular carcinoma: Effect of coadministration of lipiodol
- 31 July 1991
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 13 (1) , 120-127
- https://doi.org/10.1016/0168-8278(91)90873-a
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Transcatheter Treatment of Hepatocellular Carcinoma with Doxorubicin-loaded DC Bead (DEBDOX): Technical RecommendationsCardioVascular and Interventional Radiology, 2011
- A new approach to chemoembolization therapy for hepatoma using ethiodized oil, cisplatin, and gelatin spongeCancer, 1987
- Significance of serum bilirubin level in response of hepatocellular carcinoma to doxorubicinJournal of Hepatology, 1986
- Selective targeting of anti-cancer drug and simultaneous image enhancement in solid tumors by arterially administered lipid contrast mediumCancer, 1984
- Hepatic extraction of adriamycin in patients with hepatocellular carcinomaEuropean Journal of Cancer and Clinical Oncology, 1984
- STRIPE: An interactive computer program for the analysis of drug pharmacokineticsJournal of Pharmacological Methods, 1983
- A pharmacokinetic analysis program (multi) for microcomputer.Journal of Pharmacobio-Dynamics, 1981
- INDUCTION OF REMISSION IN HEPATOCELLULAR CARCINOMA WITH DOXORUBICINThe Lancet, 1978
- Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equationsJournal of Pharmacokinetics and Biopharmaceutics, 1978
- A critical evaluation of the principles governing the advantages of intra-arterial infusionsJournal of Pharmacokinetics and Biopharmaceutics, 1974